Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMMX stock hub

Immix Biopharma, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMMXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

516.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMMX

In the news

Latest news · IMMX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-46.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMMX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001873835
Company name	Immix Biopharma, Inc.
Country	United States
Country code	US
Cusip	45258H106
Employees	21
Employees Change	4%
Employees Change Percent	23.53
Enterprise value	$427.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-12-16
Isin	US45258H1068
Last refreshed	2026-05-10
Market cap	$516.9M
Market cap category	Small-Cap
Price	$9.75
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	IMMX
Website	https://www.immixbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.77%
FCF yield	-4.77%
P/B ratio	6.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-35M
Net Income Growth Years	0%
Profit Per Employee	$-1.7M
ROA	-38.97
Roa5y	-38.68
ROCE	-42.31
ROE	-74.47
Roe5y	-145.8
ROIC	-46.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	360.39%
Cagr3y	53.79%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$95.8M
Cash	$90.6M
Current Assets	$101.2M
Current Liabilities	$10.1M
Debt	$1M
Debt Equity	$0.01
Equity	$84.4M
Liabilities	$11.5M
Long Term Assets	$-5.4M
Long Term Liabilities	$1.3M
Net Cash	$89.5M
Net Cash By Market Cap	$17.32
Net Cash Growth	498.15%
Net Debt Equity	$-1.06
Tangible Book Value	$84.4M
Tangible Book Value Per Share	$1.59
WACC	4.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.76
Net Working Capital	$-8.7M
Quick ratio	8.59
Working Capital	$81.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	359.91%
200-day SMA	5.39
3Y total return	263.81%
50-day SMA	9.39
50-day SMA vs 200-day SMA	50over200
All Time High	11.61
All Time High Change	-16.02%
All Time High Date	2026-03-17
All Time Low	0.68
All Time Low Change	1,333.82%
All Time Low Date	2022-11-10
ATR	0.79
Beta	0.12
Beta1y	0.25
Beta2y	1.24
Ch YTD	86.42
High	10.08
High52	11.61
High52 Date	2026-03-17
High52ch	-16.02%
Low	9.18
Low52	1.87
Low52 Date	2025-06-03
Low52ch	421.39%
Ma50ch	3.82%
Price vs 200-day SMA	80.96%
RSI	53
RSI Monthly	79.18
RSI Weekly	65.58
Sharpe ratio	2.1x
Sortino ratio	3.6
Total Return	-16.55%
Tr YTD	86.42
Tr1m	7.26%
Tr1w	4.84%
Tr3m	44.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$16.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.21
Operating Income	$-36.1M
Price target	$19.2
Price Target Change	$96.92
Price Target Change Top	$70.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,297,641%
Float Percent	74.13%
Shares Insiders	12.83%
Shares Institutions	44.09%
Shares Out	53,012,092
Shares Qo Q	25.99%
Shares Yo Y	16.55%
Short Float	7.54%
Short Ratio	3.51
Short Shares	5.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-26.8M
Average Volume	719,830.9x
Bv Per Share	1.59
CAPEX	$-697,698
Ch1m	7.26
Ch1w	4.84
Ch1y	359.9
Ch3m	44.66
Ch3y	263.8
Ch6m	209.5
Change	2.2%
Change From Open	4.06
Close	9.54
Days Gap	-1.78
Depreciation Amortization	245,747
Dollar Volume	6,446,534.3
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-36.1M
EBITDA	$-35.8M
EPS	$-0.89
F Score	2
FCF	$-24.7M
FCF EV Yield	-5.77x
FCF Per Share	$-0.47
Financing CF	107,349,298
Fiscal Year End	December
Founded	2,014
Income Tax	$27,902
Investing CF	-11,946,908
Ipr	95
Iprfo	95
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	6.43
Ma150ch	51.75%
Ma20	9.68
Ma20ch	0.78%
Net CF	63,329,062
Next Earnings Date	2026-05-22
Open	9.37
Optionable	Yes
Position In Range	63.33
Post Close	9.75
Postmarket Change Percent	-5.82
Postmarket Price	$9.18
Ppne	3,488,538
Price Date	2026-05-08
Ptbv Ratio	6.13
Relative Volume	0.92x
Share Based Comp	2,149,081
Tr6m	209.52%
Us State	California
Volume	661,183

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMMX pay a dividend?

Capital-return profile for this ticker.

Performance

IMMX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMMX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.1%

Float: +74.1% of shares outstanding

Insider ownership

+12.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMMX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.0

Neutral momentum band

Price vs 200-day MA

+81.0%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

2.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMMX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMMX stock rating?

Immix Biopharma, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMMX analysis?

The full report lives at /stocks/IMMX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMMX?

The latest report frames IMMX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMMX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.